MAXINE LUBKIN: Open Payments
NPI 1841215795 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,318 in 90 payments from 14 companies in 2025. Trend: 2023 $1,626 · 2024 $2,052 · 2025 $1,318
Food & beverage: $1,308Education: $10
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 45 | $417 |
| ABBVIE INC. | 15 | $243 |
| Janssen Biotech, Inc. | 9 | $185 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $94 |
| Regeneron Healthcare Solutions, Inc. | 2 | $62 |
| PFIZER INC. | 3 | $58 |
| Ardelyx, Inc. | 2 | $57 |
| Lilly USA, LLC | 3 | $56 |
| Sandoz Inc. | 2 | $48 |
| Organon LLC | 1 | $28 |
Products named: XIFAXAN, TREMFYA, RINVOQ, ENTYVIO, DUPIXENT, LINZESS, IBSRELA, OMVOH.
Industry payments across NY — which companies pay providers there.
